The potential for antimicrobial drug use in veterinary medicine to contribute to antimicrobial resistance in humans has been a focus of federal agencies for decades, and in recent years FDA and USDA have launched sweeping new initiatives to address this concern. This session will explore FDA and USDA’s efforts to combat antimicrobial resistance and towards judicious antimicrobial use through industry guidance, initiatives, and communication with global partners.
Patrick C. Gallagher, Principal, PC Gallagher Law, P.A.
Karl M. Nobert, Senior Counsel, Michael Best & Friedrich LLP
Moderated by Elizabeth Butterworth Stutts, Principal, Elizabeth Butterworth Stutts, Esq, PLLC
Related People
Preview Attorney's BiographyKarl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food and drug industries with regard to pharmaceuticals and OTC drugs, biologics, medical devices, food and beverages including dairy products, cosmetics, vitamins and dietary supplements, and veterinary products.